AI-enhanced precision: boosting pathologist confidence in HER2 ultra-low diagnosis through intelligent re-screening
{{output}}
Accurate assessment of Human Epidermal Growth Factor Receptor 2 (HER2) immunohistochemistry (IHC) expression, particularly the precise identification of "HER2 ultra-low" status, is critical for guiding antibody-drug conjugate (ADC) therapies, such as trastuz... ...
